No FDA-approved product
BPC-157
BPC-157 has no FDA-approved product. This page cites 3 sources, and the strongest evidence comes from animal studies.
- Status
- No FDA-approved product
- Form
- Injection
- Half-life
- Not modeled
- Strongest evidence
- Animal studies
- Cited claims
- 2
- Last updated
- November 6, 2026
What the evidence says
Each claim names the kind of study behind it, what it can't tell you, and where it comes from.
Animal studies
BPC-157 improved tendon and gut healing in rat injury studies.
Limits: Animal injury models do not establish benefit or safety in people. This claim covers rat tendon and intestinal surgical-wound experiments.
Lab studies
Rat-derived tendon tissue and cells showed changes in outgrowth and migration.
Limits: A laboratory signal cannot tell us whether a treatment helps patients.
Regulatory status
United States
Not an FDA-approved medicine. FDA reports insufficient safety information for proposed compounded routes.